Intermittent hypobaric hypoxia applicability in myocardial infarction prevention and recovery

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 5, 2012, Pages 1150-1154

  Sanchis Gomar, Fabian ^a,b   Viña, Jose ^a,b   Lippi, Giuseppe ^c  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c ACADEMIC HOSPITAL OF PARMA   (Italy)

Author keywords

Cardioprotection; Endothelium; Erythropoietin; Hypobaric chamber; Hypoxia inducible factor

Indexed keywords

ALTITUDE; ARTICLE; ATMOSPHERIC PRESSURE; HEART INFARCTION; HEART INFARCTION PREVENTION; HUMAN; METHODOLOGY;

AIR PRESSURE; ALTITUDE; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MYOCARDIAL INFARCTION;

EID: 84860326572     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01508.x     Document Type: Article

References (72)

1. Magalhaes J, Ascensao A, Viscor G, et al. Oxidative stress in humans during and after 4 hours of hypoxia at a simulated altitude of 5500 m. Aviat Space Environ Med. 2004; 75: 16-22.
2. Millet GP, Roels B, Schmitt L, et al. Combining hypoxic methods for peak performance. Sports Med. 2010; 40: 1-25.
3. Fu Q, Townsend NE, Shiller SM, et al. Intermittent hypobaric hypoxia exposure does not cause sustained alterations in autonomic control of blood pressure in young athletes. Am J Physiol Regul Integr Comp Physiol. 2007; 292: R1977-84.
4. Meeuwsen T, Hendriksen IJ, Holewijn M. Training-induced increases in sea-level performance are enhanced by acute intermittent hypobaric hypoxia. Eur J Appl Physiol. 2001; 84: 283-90.
5. Ventura N, Hoppeler H, Seiler R, et al. The response of trained athletes to six weeks of endurance training in hypoxia or normoxia. Int J Sports Med. 2003; 24: 166-72.
6. Wang ZH, Chen YX, Zhang CM, et al. Intermittent hypobaric hypoxia improves postischaemic recovery of myocardial contractile function via redox signaling during early reperfusion. Am J Physiol Heart Circ Physiol. 2011; 301: H1695-705.
7. Xu WQ, Yu Z, Xie Y, et al. Therapeutic effect of intermittent hypobaric hypoxia on myocardial infarction in rats. Basic Res Cardiol. 2011; 106: 329-42.
8. 2+ exchange mechanisms. Am J Physiol Cell Physiol. 2006; 290: C1221-9.
9. Yu Z, Wang ZH, Yang HT. Calcium/calmodulin-dependent protein kinase II mediates cardioprotection of intermittent hypoxia against ischaemic-reperfusion-induced cardiac dysfunction. Am J Physiol Heart Circ Physiol. 2009; 297: H735-42.
10. Dong JW, Zhu HF, Zhu WZ, et al. Intermittent hypoxia attenuates ischaemia/reperfusion induced apoptosis in cardiac myocytes via regulating Bcl-2/Bax expression. Cell Res. 2003; 13: 385-91.
11. Kolar F, Neckar J, Ostadal B. MCC-134, a blocker of mitochondrial and opener of sarcolemmal ATP-sensitive K+ channels, abrogates cardioprotective effects of chronic hypoxia. Physiol Res. 2005; 54: 467-71.
12. Neckar J, Szarszoi O, Koten L, et al. Effects of mitochondrial K(ATP) modulators on cardioprotection induced by chronic high altitude hypoxia in rats. Cardiovasc Res. 2002; 55: 567-75.
13. Meerson FZ, Ustinova EE, Orlova EH. Prevention and elimination of heart arrhythmias by adaptation to intermittent high altitude hypoxia. Clin Cardiol. 1987; 10: 783-9.
14. Guo HC, Zhang Z, Zhang LN, et al. Chronic intermittent hypobaric hypoxia protects the heart against ischaemia/reperfusion injury through upregulation of antioxidant enzymes in adult guinea pigs. Acta Pharmacol Sin. 2009; 30: 947-55.
15. Zhang Y, Zhong N, Zhu HF, et al. Antiarrhythmic and antioxidative effects of intermittent hypoxia exposure on rat myocardium. Sheng Li Xue Bao. 2000; 52: 89-92.
16. Ding HL, Zhu HF, Dong JW, et al. Intermittent hypoxia protects the rat heart against ischaemia/reperfusion injury by activating protein kinase C. Life Sci. 2004; 75: 2587-603.
17. Belaidi E, Beguin PC, Levy P, et al. Delayed myocardial preconditioning induced by cobalt chloride in the rat: HIF-1alpha and iNOS involvement. Fundam Clin Pharmacol. 2011; in press: doi: 10.1111/j.1472-8206.2011.00940.x.
18. Wang GL, Jiang BH, Rue EA, et al. Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA. 1995; 92: 5510-4.
19. 2 homeostasis. Curr Opin Genet Dev. 1998; 8: 588-94.
20. Semenza GL. Hypoxia-inducible factor 1 and the molecular physiology of oxygen homeostasis. J Lab Clin Med. 1998; 131: 207-14.
21. Semenza GL, Agani F, Iyer N, et al. Hypoxia-inducible factor 1: from molecular biology to cardiopulmonary physiology. Chest. 1998; 114: 40S-5S.
22. 2-regulated prolyl hydroxylation. Science. 2001; 292: 468-72.
23. Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 2001; 294: 1337-40.
24. Masson N, Willam C, Maxwell PH, et al. Independent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylation. EMBO J. 2001; 20: 5197-206.
25. Lippi G, Montagnana M, Guidi GC. Albumin cobalt binding and ischaemia modified albumin generation: an endogenous response to ischaemia? Int J Cardiol. 2006; 108: 410-1.
26. 2 sensing. Science. 2001; 292: 464-8.
27. Bell EL, Chandel NS. Mitochondrial oxygen sensing: regulation of hypoxia-inducible factor by mitochondrial generated reactive oxygen species. Essays Biochem. 2007; 43: 17-27.
28. Bell EL, Klimova TA, Eisenbart J, et al. The Qo site of the mitochondrial complex III is required for the transduction of hypoxic signaling via reactive oxygen species production. J Cell Biol. 2007; 177: 1029-36.
29. Brunelle JK, Bell EL, Quesada NM, et al. Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab. 2005; 1: 409-14.
30. 2 sensing. J Biol Chem. 2000; 275: 25130-8.
31. Qutub AA, Popel AS. Reactive oxygen species regulate hypoxia-inducible factor 1alpha differentially in cancer and ischaemia. Mol Cell Biol. 2008; 28: 5106-19.
32. Semenza GL, Shimoda LA, Prabhakar NR. Regulation of gene expression by HIF-1. Novartis Found Symp. 2006; 14: 33-6.
33. Semenza GL. Hydroxylation of HIF-1: oxygen sensing at the molecular level. Physiology (Bethesda). 2004; 19: 176-82.
34. Tekin D, Dursun AD, Xi L. Hypoxia inducible factor 1 (HIF-1) and cardioprotection. Acta Pharmacol Sin. 2011; 31: 1085-94.
35. Norton CE, Jernigan NL, Kanagy NL, et al. Intermittent hypoxia augments pulmonary vascular smooth muscle reactivity to NO: regulation by reactive oxygen species. J Appl Physiol. 2011; in press: doi: 10.1152/japplphysiol.01286.2010.
36. Clanton TL. Hypoxia-induced reactive oxygen species formation in skeletal muscle. J Appl Physiol. 2007; 102: 2379-88.
37. Dosek A, Ohno H, Acs Z, et al. High altitude and oxidative stress. Respir Physiol Neurobiol. 2007; 158: 128-31.
38. Pialoux V, Hanly PJ, Foster GE, et al. Effects of exposure to intermittent hypoxia on oxidative stress and acute hypoxic ventilatory response in humans. Am J Respir Crit Care Med. 2009; 180: 1002-9.
39. Radak Z, Asano K, Lee KC, et al. High altitude training increases reactive carbonyl derivatives but not lipid peroxidation in skeletal muscle of rats. Free Radic Biol Med. 1997; 22: 1109-14.
40. Devi SA, Vani R, Subramanyam MV, et al. Intermittent hypobaric hypoxia-induced oxidative stress in rat erythrocytes: protective effects of vitamin E, vitamin C, and carnitine. Cell Biochem Funct. 2007; 25: 221-31.
41. Penna C, Rastaldo R, Mancardi D, et al. Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K+ channel and protein kinase C activation. Basic Res Cardiol. 2006; 101: 180-9.
42. Tsutsumi YM, Yokoyama T, Horikawa Y, et al. Reactive oxygen species trigger ischaemic and pharmacological postconditioning: in vivo and in vitro characterization. Life Sci. 2007; 81: 1223-7.
43. Przyklenk K, Whittaker P. Cardioprotection via adaptation to hypoxia: expanding the timeline and targets? Basic Res Cardiol. 2011; 106: 325-8.
44. Brugniaux JV, Pialoux V, Foster GE, et al. Effects of intermittent hypoxia on erythropoietin, soluble erythropoietin receptor and ventilation in humans. Eur Respir J. 2011; 37: 880-7.
45. Mackenzie RW, Watt PW, Maxwell NS. Acute normobaric hypoxia stimulates erythropoietin release. High Alt Med Biol. 2008; 9: 28-37.
46. Sanchis-Gomar F, Martinez-Bello VE, Domenech E, et al. Effect of intermittent hypoxia on hematological parameters after recombinant human erythropoietin administration. Eur J Appl Physiol. 2009; 107: 429-36.
47. Martinez-Bello VE, Sanchis-Gomar F, Nascimento AL, et al. Living at high altitude in combination with sea-level sprint training increases hematological parameters but does not improve performance in rats. Eur J Appl Physiol. 2011; 111: 1147-56.
48. Lippi G, Franchini M. Intermittent hypoxic training: doping or what? Eur J Appl Physiol. 2010; 108: 411-2.
49. Lippi G, Franchini M, Guidi GC. Prohibition of artificial hypoxic environments in sports: health risks rather than ethics. Appl Physiol Nutr Metab. 2007; 32: 1206-7; discussion 8-9.
50. Richter V, Savery MD, Gassmann M, et al. Excessive erythrocytosis compromises the blood-endothelium interface in erythropoietin-overexpressing mice. J Physiol. 2011; in press: doi: 10.1113/jphysiol.2011.209262.
51. Greenberg G, Assali A, Vaknin-Assa H, et al. Hematocrit level as a marker of outcome in ST-segment elevation myocardial infarction. Am J Cardiol. 2010; 105: 435-40.
52. Lippi G, Franchini M, Targher G. Arterial thrombus formation in cardiovascular disease. Nat Rev Cardiol. 2011; in press: doi: 10.1038/nrcardio.2011.91.
53. Ramond A, Ribuot C, Levy P, et al. Deleterious myocardial consequences induced by intermittent hypoxia are reversed by erythropoietin. Respir Physiol Neurobiol. 2007; 156: 362-9.
54. Stray-Gundersen J, Levine BD. Live high, train low at natural altitude. Scand J Med Sci Sports. 2008; 18(Suppl. 1): 21-8.
55. Richalet JP, Gore CJ. Live and/or sleep high:train low, using normobaric hypoxia. Scand J Med Sci Sports. 2008; 18(Suppl. 1): 29-37.
56. Bartsch P, Dehnert C, Friedmann-Bette B, et al. Intermittent hypoxia at rest for improvement of athletic performance. Scand J Med Sci Sports. 2008; 18(Suppl. 1): 50-6.
57. Wilber RL, Stray-Gundersen J, Levine BD. Effect of hypoxic "dose" on physiological responses and sea-level performance. Med Sci Sports Exerc. 2007; 39: 1590-9.
58. Julian CG, Gore CJ, Wilber RL, et al. Intermittent normobaric hypoxia does not alter performance or erythropoietic markers in highly trained distance runners. J Appl Physiol. 2004; 96: 1800-7.
59. Roels B, Millet GP, Marcoux CJ, et al. Effects of hypoxic interval training on cycling performance. Med Sci Sports Exerc. 2005; 37: 138-46.
60. Truijens MJ, Toussaint HM, Dow J, et al. Effect of high-intensity hypoxic training on sea-level swimming performances. J Appl Physiol. 2003; 94: 733-43.
61. Neya M, Enoki T, Kumai Y, et al. The effects of nightly normobaric hypoxia and high intensity training under intermittent normobaric hypoxia on running economy and hemoglobin mass. J Appl Physiol. 2007; 103: 828-34.
62. Esteva S, Pedret R, Fort N, et al. Oxidative stress status in rats after intermittent exposure to hypobaric hypoxia. Wilderness Environ Med. 2010; 21: 325-31.
63. Vani R, Reddy CS, Asha Devi S. Oxidative stress in erythrocytes: a study on the effect of antioxidant mixtures during intermittent exposures to high altitude. Int J Biometeorol. 2010; 54: 553-62.
64. Drager LF, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest. 2011; 140: 534-42.
65. Fava C, Montagnana M, Favaloro EJ, et al. Obstructive sleep apnea syndrome and cardiovascular diseases. Semin Thromb Hemost. 2011; 37: 280-97.
66. Park AM, Suzuki YJ. Effects of intermittent hypoxia on oxidative stress-induced myocardial damage in mice. J Appl Physiol. 2007; 102: 1806-14.
67. Drager LF, Li J, Reinke C, et al. Intermittent hypoxia exacerbates metabolic effects of diet-induced obesity. Obesity (Silver Spring). 2011; in press: doi: 10.1038/oby.2011.240.
68. Genovese A, Latte S, Bozzaotre M, et al. Response of the left ventricular connective tissue to hypoxia. Res Exp Med (Berl). 1983; 183: 111-5.
69. Siebenmann C, Bloch KE, Lundby C, et al. Dexamethasone improves maximal exercise capacity of individuals susceptible to high altitude pulmonary edema at 4559 m. High Alt Med Biol. 2011; 12: 169-77.
70. Zhou Q. Standardization of methods for early diagnosis and on-site treatment of high-altitude pulmonary edema. Pulm Med. 2011; 2011: 190648.
71. Hall DP, Duncan K, Baillie JK. High altitude pulmonary oedema. J R Army Med Corps. 2011; 157: 68-72.
72. Anderson JD, Honigman B. The effect of altitude-induced hypoxia on heart disease: do acute, intermittent, and chronic exposures provide cardioprotection? High Alt Med Biol. 2011; 12: 45-55.